(S,S)-5(2-[3-(benzothiazol-2-yloxy)-phenyl]-ethyl)-2,5-diaza-bicyclo[2.2.1]hetpane-2-carboxylic acid amide | 1146691-87-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (S,S)-5(2-[3-(benzothiazol-2-yloxy)-phenyl]-ethyl)-2,5-diaza-bicyclo[2.2.1]hetpane-2-carboxylic acid amide
• 英文别名: (1S,4S)-5-[2-[3-(1,3-benzothiazol-2-yloxy)phenyl]ethyl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxamide
• CAS: 1146691-87-3
• 化学式: C₂₁H₂₂N₄O₂S
• 分子量: 394.497
• InChiKey: NILFHOZAPKJIPP-HOTGVXAUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  99.9
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
  申请人：Bacani Genesis M.

  公开号：US20090111794A1

  公开（公告）日：2009-04-30

  Aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and the pharmaceutical compositions for leukotriene A 4 hydrolase (LTA 4 H or LTA4H) modulation and for the treatment of disease states, disorders, and conditions mediated by LTA 4 H activity, such as allergy, asthma, autoimmune diseases, pruritis, inflammatory bowel disease, ulcerative colitis, and cardiovascular disease, including atherosclerosis and prevention of myocardial infarction.

  芳基取代的桥接或融合二胺化合物，含有它们的药物组合物，以及使用这些化合物和药物组合物进行白三烯A4水解酶（LTA4H）调节和治疗由LTA4H活性介导的疾病状态、疾病和疾病，如过敏、哮喘、自身免疫疾病、瘙痒、炎症性肠病、溃疡性结肠炎和心血管疾病，包括动脉粥样硬化和预防心肌梗死的方法。
• Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
  申请人：Bacani Genesis M.

  公开号：US20110257153A1

  公开（公告）日：2011-10-20

  Aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and the pharmaceutical compositions for leukotriene A 4 hydrolase (LTA 4 H or LTA4H) modulation and for the treatment of disease states, disorders, and conditions mediated by LTA 4 H activity, such as allergy, asthma, autoimmune diseases, pruritis, inflammatory bowel disease, ulcerative colitis, and cardiovascular disease, including atherosclerosis and prevention of myocardial infarction.

  芳基取代的桥联或融合二胺化合物，含有它们的药物组合物，以及使用这些化合物和药物组合物调节白三烯A4水解酶（LTA4H或LTA4H）并治疗由LTA4H活性介导的疾病状态，疾病和情况的方法，例如过敏，哮喘，自身免疫疾病，瘙痒，炎症性肠病，溃疡性结肠炎和心血管疾病，包括动脉粥样硬化和预防心肌梗死。
• US8344008B2
  申请人：——

  公开号：US8344008B2

  公开（公告）日：2013-01-01
• US8367719B2
  申请人：——

  公开号：US8367719B2

  公开（公告）日：2013-02-05